- -

Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy

Show full item record

Fleitas-Kanonnikoff, T.; Martinez-Ciarpaglini, C.; Ayala, J.; Gauna, C.; Denis, R.; Yoffe, I.; Sforza, S.... (2019). Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy. Wiley Interdisciplinary Reviews. Computational Molecular Science (Online). 8(6):3120-3130. https://doi.org/10.1002/cam4.2191

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/158514

Files in this item

Item Metadata

Title: Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Author: Fleitas-Kanonnikoff, Tania Martinez-Ciarpaglini, Carolina Ayala, Josefina Gauna, Cinthia Denis, Rita Yoffe, Ita Sforza, Silvia Ibarrola-Villava, Maider Pomata, Alicia Ibarrola, Maider Arevshatyan, Sipan Burriel Coll, Verónica Boscá, Diego Pastor López, Oscar Ferrer-Martinez, Ana
UPV Unit: Universitat Politècnica de València. Departamento de Sistemas Informáticos y Computación - Departament de Sistemes Informàtics i Computació
Issued date:
Abstract:
[EN] Somatic mutation analysis and evaluation of microsatellite instability (MSI) have become mandatory for selecting personalized therapy strategies for advanced colorectal cancer and are not available as routine methods ...[+]
Subjects: Colorectal cancer , Microsatellite instability , Mutational profile , Oncocarta , Precision medicine
Copyrigths: Reserva de todos los derechos
Source:
Wiley Interdisciplinary Reviews. Computational Molecular Science (Online). (eissn: 1759-0884 )
DOI: 10.1002/cam4.2191
Publisher:
Wiley
Publisher version: https://doi.org/10.1002/cam4.2191
Project ID:
info:eu-repo/grantAgreement/CONACyT//PINV-156-2015/
info:eu-repo/grantAgreement/ISCIII//17%2F00026/
info:eu-repo/grantAgreement/MINECO//CD15%2F00153/ES/CD15%2F00153/
Thanks:
CONACYT Paraguay, Grant/Award Number: PINV-156/2015; INSTITUTO CARLOS III, Grant/Award Number: 17/00026 and CD15/00153; FONDOS FEDER; Bankia
Type: Artículo

References

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. doi:10.3322/caac.21492

Bray, F., & Piñeros, M. (2016). Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Pública de México, 58(2), 104-117. doi:10.21149/spm.v58i2.7779

Bohorquez, M., Sahasrabudhe, R., Criollo, A., Sanabria-Salas, M. C., Vélez, A., Castro, J. M., … Carvajal-Carmona, L. G. (2016). Clinical manifestations of colorectal cancer patients from a large multicenter study in Colombia. Medicine, 95(40), e4883. doi:10.1097/md.0000000000004883 [+]
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. doi:10.3322/caac.21492

Bray, F., & Piñeros, M. (2016). Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Pública de México, 58(2), 104-117. doi:10.21149/spm.v58i2.7779

Bohorquez, M., Sahasrabudhe, R., Criollo, A., Sanabria-Salas, M. C., Vélez, A., Castro, J. M., … Carvajal-Carmona, L. G. (2016). Clinical manifestations of colorectal cancer patients from a large multicenter study in Colombia. Medicine, 95(40), e4883. doi:10.1097/md.0000000000004883

Sartore-Bianchi, A., Trusolino, L., Martino, C., Bencardino, K., Lonardi, S., Bergamo, F., … Siena, S. (2016). Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. The Lancet Oncology, 17(6), 738-746. doi:10.1016/s1470-2045(16)00150-9

Martinez-Ciarpaglini, C., Oltra, S., Roselló, S., Roda, D., Mongort, C., Carrasco, F., … Cervantes, A. (2018). Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression. Modern Pathology, 32(2), 306-313. doi:10.1038/s41379-018-0124-5

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., … Schultz, N. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1-pl1. doi:10.1126/scisignal.2004088

Chakravarty, D., Gao, J., Phillips, S., Kundra, R., Zhang, H., Wang, J., … Schultz, N. (2017). OncoKB: A Precision Oncology Knowledge Base. JCO Precision Oncology, (1), 1-16. doi:10.1200/po.17.00011

Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2016). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4), 683-691. doi:10.1136/gutjnl-2015-310912

Ohhara, Y., Fukuda, N., Takeuchi, S., Honma, R., Shimizu, Y., Kinoshita, I., & Dosaka-Akita, H. (2016). Role of targeted therapy in metastatic colorectal cancer. World Journal of Gastrointestinal Oncology, 8(9), 642. doi:10.4251/wjgo.v8.i9.642

[-]

recommendations

 

This item appears in the following Collection(s)

Show full item record